Apimeds Pharmaceuticals US (APUS) Other Working Capital Changes (2024 - 2025)

Apimeds Pharmaceuticals US (APUS) reported Other Working Capital Changes of $193457.0 for Q4 2025, up 26456.54% on a YoY basis from N/an in Q4 2024, and down 55.12% quarter-over-quarter from $431011.0 in Q3 2025.

Apimeds Pharmaceuticals US (APUS) Other Working Capital Changes (2024 - 2025) Analysis & Trends

Apimeds Pharmaceuticals US has reported Other Working Capital Changes for 2 years, with the latest figure at $193457.0 in Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 26456.54% year-over-year to $193457.0; the trailing twelve-month figure through Dec 2025 stood at $2.4 million (up 121178.12% YoY), and the FY2025 full-year result was $2.4 million, up 121178.12% from the prior year.
  • Other Working Capital Changes for Q4 2025 stood at $193457.0, down from $431011.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $1.8 million in Q2 2025, with the low at -$1258.0 in Q1 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Apimeds Pharmaceuticals US 13.93 Mn 10.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 193,457.00
Dec 31, 2025 193,457.00
Sep 30, 2025 431,011.00
Sep 30, 2025 431,011.00
Jun 30, 2025 1.79 Mn
Jun 30, 2025 1.79 Mn
Mar 31, 2025 -40.00
Mar 31, 2025 -40.00
Dec 31, 2024 -734.00
Dec 31, 2024 -734.00
Jun 30, 2024 -1.00
Jun 30, 2024 -1.00
Mar 31, 2024 -1,258.00
Mar 31, 2024 -1,258.00